Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas.

Blood
Amrita KrishnanStephen J Forman

Abstract

The treatment of HIV-associated lymphoma has changed since the widespread use of highly active antiretroviral therapy. HIV-infected individuals can tolerate more intensive chemotherapy, as they have better hematologic reserves and fewer infections. This has led to higher response rates in patients with HIV-associated Hodgkin disease (HD) or non-Hodgkin lymphoma (NHL) treated with chemotherapy in conjunction with antiretroviral therapy. However, for patients with refractory or relapsed disease, salvage chemotherapy still offers little chance of long-term survival. In the non-HIV setting, patients with relapsed Hodgkin disease (HD) or non-Hodgkin lymphoma (NHL) have a better chance of long-term remission with high-dose chemotherapy with autologous stem cell rescue (ASCT) compared with conventional salvage chemotherapy. In a prior report we demonstrated that this approach is well tolerated in patients with underlying immunodeficiency from HIV infection. Furthermore, similar engraftment to the non-HIV setting and low infectious risks have been observed. Herein, we expand upon this early experience with the largest single institution series of 20 patients. With long-term follow-up we demonstrate that ASCT can lead to an 85% progress...Continue Reading

References

Aug 26, 1998·Journal of the National Cancer Institute. Monographs·A M Levine
Nov 9, 2000·Lancet·A MocroftJ D Lundgren
Nov 18, 2000·Journal of the National Cancer Institute·UNKNOWN International Collaboration on HIV and Cancer
Feb 28, 2003·Transplantation·Michelle E Roland, Peter G Stock
Oct 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alessandro ReMaurizio Mazzuccato
Oct 6, 2005·Bone Marrow Transplantation·G La NasaL Contu

❮ Previous
Next ❯

Citations

May 2, 2012·Current Hematologic Malignancy Reports·Nihal Martis, Nicolas Mounier
Jun 16, 2010·Current HIV/AIDS Reports·David SerranoJuan Berenguer
Aug 4, 2012·Bone Marrow Transplantation·S O AhmedM Aljurf
Apr 17, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lijing LiDavid L DiGiusto
Dec 16, 2005·Cell Research·Charles Wood, William Harrington
Aug 9, 2006·Current Opinion in Oncology·Caroline M Behler, Lawrence D Kaplan
Jun 2, 2005·Current Opinion in Hematology·Bertrand Coiffier
Dec 24, 2005·Current Opinion in Infectious Diseases·Mark BowerTony Dhillon
Feb 28, 2008·Current Opinion in Oncology·Nina D Wagner-Johnston, Richard F Ambinder
Jul 20, 2010·Current Opinion in Oncology·Amrita Krishnan, Stephen J Forman
Apr 3, 2009·Current Opinion in HIV and AIDS·Amrita Krishnan
Dec 10, 2013·Hematology·John A Zaia, Stephen J Forman
Oct 29, 2008·Blood·Antonino CarboneThomas F Schulz
Mar 25, 2009·Blood·José L Díez-MartínUNKNOWN European Group for Blood and Marrow Transplantation Lymphoma Working Party
Feb 24, 2006·Proceedings of the American Thoracic Society·Henry Masur
Aug 27, 2013·Haematologica·Alessandro ReUNKNOWN Cooperative European Group on AIDS and Tumors
Aug 15, 2014·Current Infectious Disease Reports·Ignacio A EcheniqueChristine M Durand
Jun 8, 2014·Current Hematologic Malignancy Reports·James Aries, Silvia Montoto
Dec 17, 2008·Women's Health·Amrita Krishnan, Alexandra M Levine
Jan 25, 2012·Advances in Hematology·Caron A Jacobson, Jeremy S Abramson
Mar 9, 2012·Advances in Hematology·Prakash Vishnu, David M Aboulafia
Nov 30, 2013·Viruses·Patrick YounanHans-Peter Kiem
Nov 23, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Pilar MirallesUNKNOWN Grupo de Estudio del SIDA Register of Systemic AIDS-Related Lymphomas
Apr 3, 2009·Current Opinion in HIV and AIDS·Antonino CarboneMichele Spina
May 1, 2009·Expert Review of Clinical Pharmacology·Antonello MalfitanoGiorgio Barbarini
Aug 4, 2009·Expert Opinion on Biological Therapy·Thomas Newsom-DavisMark Bower
Aug 24, 2010·Expert Opinion on Pharmacotherapy·Michele SpinaAntonino Carbone
Jul 18, 2012·Cytotherapy·David L Digiusto, Hans-Peter Kiem
Mar 14, 2012·Best Practice & Research. Clinical Haematology·Lawrence D Kaplan
Aug 13, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Christine JohnstonAnn Woolfrey
Oct 29, 2008·Hematology/oncology Clinics of North America·David Wrench, John G Gribben
Oct 13, 2007·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Gerhard SissolakPeter Jacobs
Jun 21, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Monzr M Al-MalkiAlessandro Re

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.